| GSK | 20-Mar-26 |
Buy |
Jonathan Symonds |
1,950.85p | 5,000 |
£97,542.50 |
| GSK | 20-Mar-26 |
Buy |
Wendy Becker |
1,962.50p | 411 |
£8,065.88 |
| GSK | 20-Mar-26 |
Buy |
Elizabeth (Liz) McKee Anderson |
$51.79 | 196 |
$8,371.08 |
| GSK | 20-Mar-26 |
Buy |
Charles Bancroft |
$51.79 | 1,536 |
$65,601.90 |
| GSK | 20-Mar-26 |
Buy |
Anne Beal |
5,179.39p | 196 |
£10,151.60 |
| GSK | 18-Mar-26 |
Buy |
Gavin Screaton |
1,962.94p | 6,335 |
£124,352.25 |
| GSK | 20-Mar-26 |
Buy |
Jonathan Symonds |
1,950.85p | 5,000 |
£97,542.50 |
| GSK | 20-Mar-26 |
Buy |
Charles Bancroft |
$51.79 | 1,536 |
$65,601.90 |
| GSK | 20-Mar-26 |
Buy |
Vishal Sikka |
$51.79 | 797 |
$34,039.53 |
| GSK | 20-Mar-26 |
Buy |
Anne Beal |
5,179.39p | 196 |
£10,151.60 |
| BT.A |
206.60p |
+3.5% |
| XAR |
105.00p |
+3.4% |
| APTD |
220.00p |
+2.8% |
| VOD |
110.10p |
+2.2% |
| GSK |
1,977.00p |
+2.1% |
| SN. |
1,205.00p |
+1.5% |
| OXIG |
2,460.00p |
+0.8% |
| TRD |
295.00p |
+0.3% |
| BVC |
12.95p |
-2.3% |
| QQ. |
467.40p |
-1.9% |
| GNS |
2,490.00p |
-1.8% |
| CCC |
2,828.00p |
-1.7% |
| SGE |
804.60p |
-1.7% |
| OXB |
593.00p |
-1.5% |
| DIA |
280.00p |
-1.4% |
| RM. |
91.50p |
-1.1% |
| XPP |
1,272.00p |
-0.9% |
| NCC |
115.40p |
-0.7% |
Top of Page
You are here:
research